Glück Conviction Score™ ⓘ
ABVX
Abivax S.A.
⚠
Kein belastbares Signal — erst 21 % der Signal-Gewichte sind mit Daten unterlegt — z. B. junger Filer ohne ausreichende Historie.
Effektiv: Kein belastbares Signal
Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
23,7
56 neu, 117 erhöht, -2218440K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 115.90 | -16.7 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 110.62 | -12.7 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 108.05 | EMA50: 113.31 | |
| MACD-Histogramm | Bärisch | 10 % | -1.694 | Bearisch | |
| RSI(14) | Neutral | 10 % | 41.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 41.0 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 20.5 | +DI: 20.5 / −DI: 31.7 | |
| Z-Score(60) | Bullisch | 5 % | -1.75 | Extrem überverkauft | |
| 52W-Position | Neutral | 5 % | 65.0 % | Hoch 145.31 / Tief 5.97 | |
| Bollinger(20,2σ) | Neutral | 5 % | 26.4 % | Upper 142.29 / Mid 111.23 / Lower 80.16 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.1335 | R²=0.05 / annualisiert -29.2 % |
Insider-Transaktionen (12 Monate) ⓘ
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 6.481.085 | 7.111.596 | -630.511 | 721.668.815 | Reduziert | -8,9% | |
| UBS Group AG | 4.547.406 | 4.423.906 | 123.500 | 506.353.658 | Aufgestockt | +2,8% | |
| Darwin Global Management, Ltd. | 3.468.657 | 3.178.501 | 290.156 | 352.068.686 | Aufgestockt | +9,1% | |
| MORGAN STANLEY | 1.704.958 | 3.151.994 | -1.447.036 | 189.847.183 | Reduziert | -45,9% | |
| Vestal Point Capital, LP | 1.500.000 | 1.900.000 | -400.000 | 167.025.000 | Reduziert | -21,1% | |
| Caligan Partners LP | 1.461.924 | 1.451.924 | 10.000 | 162.785.237 | Aufgestockt | +0,7% | |
| ADAR1 Capital Management, LLC | 1.438.019 | 1.317.329 | 120.690 | 160.123.416 | Aufgestockt | +9,2% | |
| CITADEL ADVISORS LLC | 1.339.038 | 1.083.547 | 255.491 | 149.101.882 | Aufgestockt | +23,6% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.322.938 | 1.009.966 | 312.972 | 147.309.146 | Aufgestockt | +31,0% | |
| FMR LLC | 1.286.373 | 1.365.657 | -79.284 | 143.237.633 | Reduziert | -5,8% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.284.782 | 1.488.636 | -203.854 | 143.060.476 | Reduziert | -13,7% | |
| Helikon Investments Ltd | 1.013.324 | 0 | 1.013.324 | 112.833.627 | Neu | +100,0% | |
| Eversept Partners, LP | 934.423 | 657.834 | 276.589 | 104.048.001 | Aufgestockt | +42,0% | |
| DEUTSCHE BANK AG\ | 764.899 | 0 | 764.899 | 103.154.279 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 878.829 | 667.761 | 211.068 | 98.007.010 | Aufgestockt | +31,6% | |
| BAKER BROS. ADVISORS LP | 875.796 | 875.796 | 0 | 97.519.885 | Unverändert | 0,0% | |
| Paradigm Biocapital Advisors LP | 772.473 | 1.417.473 | -645.000 | 86.014.869 | Reduziert | -45,5% | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 765.915 | 691.973 | 73.942 | 85.284.635 | Aufgestockt | +10,7% | |
| Cormorant Asset Management, LP | 760.000 | 1.350.000 | -590.000 | 84.626.000 | Reduziert | -43,7% | |
| BANK OF AMERICA CORP /DE/ | 735.729 | 522.289 | 213.440 | 81.923.424 | Aufgestockt | +40,9% | |
| Octagon Capital Advisors LP | 677.000 | 756.000 | -79.000 | 75.383.950 | Reduziert | -10,4% | |
| Logos Global Management LP | 675.000 | 400.000 | 275.000 | 75.161.250 | Aufgestockt | +68,8% | |
| Point72 Asset Management, L.P. | 647.236 | 2.909.154 | -2.261.918 | 72.069.729 | Reduziert | -77,8% | |
| Ensign Peak Advisors, Inc | 631.838 | 518.347 | 113.491 | 70.355.161 | Aufgestockt | +21,9% | |
| MILLENNIUM MANAGEMENT LLC | 621.092 | 741.060 | -119.968 | 69.158.594 | Reduziert | -16,2% | |
| BVF INC/IL | 508.031 | 0 | 508.031 | 68.510.521 | Neu | +100,0% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 559.261 | 543.181 | 16.080 | 62.273.712 | Aufgestockt | +3,0% | |
| JPMORGAN CHASE & CO | 456.523 | 0 | 456.523 | 61.564.409 | Neu | +100,0% | |
| Saturn V Capital Management LP | 542.696 | 649.179 | -106.483 | 60.429.200 | Reduziert | -16,4% | |
| First Turn Management, LLC | 465.869 | 381.233 | 84.636 | 51.874.513 | Aufgestockt | +22,2% | |
| ORBIMED ADVISORS LLC | 465.700 | 367.900 | 97.800 | 51.855.695 | Aufgestockt | +26,6% | |
| Frazier Life Sciences Management, L.P. | 378.300 | 0 | 378.300 | 51.015.647 | Neu | +100,0% | |
| Aberdeen Group plc | 431.241 | 426.658 | 4.583 | 48.018.685 | Aufgestockt | +1,1% | |
| BlackRock, Inc. | 427.335 | 436.713 | -9.378 | 47.583.752 | Reduziert | -2,1% | |
| Affinity Asset Advisors, LLC | 405.000 | 505.000 | -100.000 | 45.096.750 | Reduziert | -19,8% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400.539 | 550.000 | -149.461 | 44.600.018 | Reduziert | -27,2% | |
| FRANKLIN RESOURCES INC | 382.830 | 449.121 | -66.291 | 42.628.121 | Reduziert | -14,8% | |
| Ikarian Capital, LLC | 350.935 | 331.085 | 19.850 | 38.891.647 | Aufgestockt | +6,0% | |
| GOLDMAN SACHS GROUP INC | 348.797 | 263.533 | 85.264 | 38.838.546 | Aufgestockt | +32,4% | |
| PERCEPTIVE ADVISORS LLC | 328.884 | 458.343 | -129.459 | 36.621.233 | Reduziert | -28,2% | |
| IMC-Chicago, LLC | 326.743 | 85.919 | 240.824 | 36.382.833 | Aufgestockt | +280,3% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 320.576 | 327.911 | -7.335 | 35.693.527 | Reduziert | -2,2% | |
| STEMPOINT CAPITAL LP | 313.791 | 391.783 | -77.992 | 34.940.628 | Reduziert | -19,9% | |
| PRINCIPAL FINANCIAL GROUP INC | 312.274 | 217.890 | 94.384 | 34.771.708 | Aufgestockt | +43,3% | |
| ExodusPoint Capital Management, LP | 251.473 | 0 | 251.473 | 33.913.658 | Neu | +100,0% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 302.530 | 422.193 | -119.663 | 33.686.716 | Reduziert | -28,3% | |
| DIADEMA PARTNERS LP | 275.944 | 75.644 | 200.300 | 30.487.262 | Aufgestockt | +264,8% | |
| Holocene Advisors, LP | 258.657 | 258.657 | 0 | 28.801.457 | Unverändert | 0,0% | |
| Vivo Capital, LLC | 239.539 | 359.305 | -119.766 | 26.672.668 | Reduziert | -33,3% | |
| LMR Partners LLP | 227.752 | 285.452 | -57.700 | 25.360.185 | Reduziert | -20,2% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 6.481.085 | 7.111.596 | -8,9% | 721.668.815 | 12,85 |
| UBS Group AG | 4.547.406 | 4.423.906 | +2,8% | 506.353.658 | 9,02 |
| Darwin Global Management, Ltd. | 3.468.657 | 3.178.501 | +9,1% | 352.068.686 | 6,27 |
| MORGAN STANLEY | 1.704.958 | 3.151.994 | -45,9% | 189.847.183 | 3,38 |
| Vestal Point Capital, LP | 1.500.000 | 1.900.000 | -21,1% | 167.025.000 | 2,97 |
| Caligan Partners LP | 1.461.924 | 1.451.924 | +0,7% | 162.785.237 | 2,90 |
| ADAR1 Capital Management, LLC | 1.438.019 | 1.317.329 | +9,2% | 160.123.416 | 2,85 |
| CITADEL ADVISORS LLC | 1.339.038 | 1.083.547 | +23,6% | 149.101.882 | 2,66 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.322.938 | 1.009.966 | +31,0% | 147.309.146 | 2,62 |
| FMR LLC | 1.286.373 | 1.365.657 | -5,8% | 143.237.633 | 2,55 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.284.782 | 1.488.636 | -13,7% | 143.060.476 | 2,55 |
| Helikon Investments Ltd | 1.013.324 | 0 | +100,0% | 112.833.627 | 2,01 |
| Eversept Partners, LP | 934.423 | 657.834 | +42,0% | 104.048.001 | 1,85 |
| JANUS HENDERSON GROUP PLC | 878.829 | 667.761 | +31,6% | 98.007.010 | 1,75 |
| BAKER BROS. ADVISORS LP | 875.796 | 875.796 | 0,0% | 97.519.885 | 1,74 |
| Paradigm Biocapital Advisors LP | 772.473 | 1.417.473 | -45,5% | 86.014.869 | 1,53 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 765.915 | 691.973 | +10,7% | 85.284.635 | 1,52 |
| Cormorant Asset Management, LP | 760.000 | 1.350.000 | -43,7% | 84.626.000 | 1,51 |
| BANK OF AMERICA CORP /DE/ | 735.729 | 522.289 | +40,9% | 81.923.424 | 1,46 |
| Octagon Capital Advisors LP | 677.000 | 756.000 | -10,4% | 75.383.950 | 1,34 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 252 | 57,4 | 5.869 |
| 31.12.2025 | ✓ | 246 | 64,8 | 8.540 |
| 30.09.2025 | ✓ | 167 | 55,1 | 4.596 |
| 30.06.2025 | ✓ | 43 | 30,9 | 235 |
| 31.03.2025 | ✓ | 46 | 31,8 | 199 |
| 31.12.2024 | ✓ | 48 | 30,3 | 7.071 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.009.966 | 136.198.965 |
| DEUTSCHE BANK AG\ | 764.899 | 103.154.279 |
| JPMORGAN CHASE & CO | 456.523 | 61.564.409 |
| BlackRock, Inc. | 436.713 | 58.892.931 |
| ExodusPoint Capital Management, LP | 251.473 | 33.913.658 |
| PRINCIPAL FINANCIAL GROUP INC | 217.890 | 29.383.558 |
| Squadron Capital Management LLC | 145.000 | 19.553.975 |
| TUDOR INVESTMENT CORP ET AL | 132.536 | 17.873.144 |
| JENNISON ASSOCIATES LLC | 127.907 | 17.248.899 |
| Invesco Ltd. | 125.403 | 16.911.221 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| MORGAN STANLEY | 3.151.994 | 1.681.277 | +114.3 % | 425.062.151 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.488.636 | 1.374.622 | +1205.7 % | 200.753.677 |
| BARCLAYS PLC | 1.308.789 | 1.232.447 | +1614.4 % | 176.496.740 |
| Vestal Point Capital, LP | 1.900.000 | 900.000 | +90.0 % | 256.224.500 |
| JANE STREET GROUP, LLC | 869.157 | 801.355 | +1181.9 % | 117.210.167 |
| LORD, ABBETT & CO. LLC | 849.732 | 513.026 | +152.4 % | 114.591 |
| BANK OF AMERICA CORP /DE/ | 522.289 | 426.696 | +446.4 % | 70.433.284 |
| CITADEL ADVISORS LLC | 1.083.547 | 387.862 | +55.8 % | 146.121.732 |
| BALYASNY ASSET MANAGEMENT L.P. | 493.322 | 333.102 | +207.9 % | 66.526.938 |
| JANUS HENDERSON GROUP PLC | 667.761 | 313.027 | +88.2 % | 90.037.554 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 1.350.000 | -600.000 | -30.8 % | 182.054.250 |
| Octagon Capital Advisors LP | 756.000 | -569.000 | -42.9 % | 101.950.380 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 550.000 | -427.629 | -43.7 % | 74.170.250 |
| Nantahala Capital Management, LLC | 153.235 | -404.329 | -72.5 % | 20.664.506 |
| Aberdeen Group plc | 426.658 | -360.759 | -45.8 % | 57.536.965 |
| MILLENNIUM MANAGEMENT LLC | 741.060 | -358.970 | -32.6 % | 99.935.646 |
| Holocene Advisors, LP | 258.657 | -202.644 | -43.9 % | 34.881.190 |
| Saturn V Capital Management LP | 649.179 | -152.045 | -19.0 % | 87.545.034 |
| Paradigm Biocapital Advisors LP | 1.417.473 | -146.723 | -9.4 % | 191.153.321 |
| MARSHALL WACE, LLP | 59.758 | -129.946 | -68.5 % | 8.058.365 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 11.05.2026 | Cedric Moreau | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Sofinnova Crossover I SLP | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Jacques Theurillat | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Sofinnova Partners SAS | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Kinam Hong | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Joseph Anderson | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 11.05.2026 | Antoine Papiernik | Aktivist (13D/A) | 6,70 % | 5.499.478 | -1,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On May 4, 202… |
| 13.02.2026 | Invus Public Equities Advisors, LLC | Passiv (13G/A) | 5,00 % | 3.922.995 | -3,50 pp | |
| 13.02.2026 | Raymond Debbane | Passiv (13G/A) | 5,00 % | 3.922.995 | -3,50 pp | |
| 13.02.2026 | Siren, L.L.C. | Passiv (13G/A) | 5,00 % | 3.922.995 | -3,50 pp | |
| 13.02.2026 | Invus Public Equities, L.P. | Passiv (13G/A) | 5,00 % | 3.922.995 | -3,50 pp | |
| 13.02.2026 | Invus Global Management, LLC | Passiv (13G/A) | 5,00 % | 3.922.995 | -3,50 pp | |
| 14.01.2026 | Sofinnova Partners SAS | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Kinam Hong | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Sofinnova Crossover I SLP | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Cedric Moreau | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Joseph Anderson | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Jacques Theurillat | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.01.2026 | Antoine Papiernik | Aktivist (13D/A) | 7,70 % | 6.399.478 | -1,70 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.11.2025 | Bong Y. Koh | Passiv (13G/A) | 0,80 % | 576.729 | Neu | |
| 14.11.2025 | VHCP Co-Investment Holdings III, LLC | Passiv (13G/A) | 0,80 % | 576.729 | -4,90 pp | |
| 14.11.2025 | Nimish Shah | Passiv (13G/A) | 0,80 % | 576.729 | Neu | |
| 14.11.2025 | Venrock Healthcare Capital Partners EG, L.P. | Passiv (13G/A) | 0,80 % | 576.729 | -4,90 pp | |
| 14.11.2025 | VHCP Management EG, LLC | Passiv (13G/A) | 0,80 % | 576.729 | -4,90 pp | |
| 14.11.2025 | VHCP Management III, LLC | Passiv (13G/A) | 0,80 % | 576.729 | -4,90 pp | |
| 14.11.2025 | Venrock Healthcare Capital Partners III, L.P. | Passiv (13G/A) | 0,80 % | 576.729 | -4,90 pp | |
| 14.11.2025 | Chen Yu | Passiv (13G/A) | 9,10 % | 7.111.596 | Neu | |
| 14.11.2025 | TCG Crossover Fund I, L.P. | Passiv (13G/A) | 8,30 % | 6.456.596 | Neu | |
| 14.11.2025 | TCG Crossover GP I, LLC | Passiv (13G/A) | 8,30 % | 6.456.596 | Neu | |
| 14.11.2025 | TCG Crossover Fund II, L.P. | Passiv (13G/A) | 0,80 % | 655.000 | Neu | |
| 14.11.2025 | TCG Crossover GP II, LLC | Passiv (13G/A) | 0,80 % | 655.000 | Neu | |
| 30.10.2025 | Sofinnova Crossover I SLP | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Antoine Papiernik | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Sofinnova Partners SAS | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Kinam Hong | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Cedric Moreau | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Joseph Anderson | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 30.10.2025 | Jacques Theurillat | Aktivist (13D/A) | 9,40 % | 8.399.478 | -2,00 pp | Item 4 of the Schedule 13D is hereby amended and supplemented as follows: SC sold the a… |
| 14.08.2025 | Deep Track Capital, LP | Passiv (13G/A) | 4,78 % | 3.480.144 | -0,30 pp | |
| 14.08.2025 | Deep Track Biotechnology Master Fund, Ltd. | Passiv (13G/A) | 4,78 % | 3.480.144 | -0,30 pp |
Stammdaten
Abivax S.A., die als ABIVAX Société Anonyme tätig ist, ist ein französisches Pharmaunternehmen, das sich auf die Entdeckung und Optimierung von Arzneimitteln zur Behandlung von Entzündungs-, Infektions- und Krebserkrankungen konzentriert. Ein Eckpfeiler seiner Produktpipeline ist ABX464, das sich derzeit in Phase-IIb-klinischen Studien für Colitis ulcerosa, Morbus Crohn und COVID-19 befindet. Diese Verbindung wird auch in Phase-IIa-Studien für rheumatoide Arthritis evaluiert und hat Phase-IIa-Studien mit nachgewiesener Virussuppression bei HIV-Patienten erfolgreich abgeschlossen. Darüber hinaus bringt das Unternehmen ABX 196, einen immunverstärkenden Kandidaten, durch Phase-1/2-klinische Studien für hepatozelluläres Karzinom voran. Abivax führt auch Forschungsinitiativen für Erkrankungen wie Dengue-Fieber, Grippe und Respiratory-Syncytial-Virus durch. Das Unternehmen hat Lizenzvereinbarungen mit wichtigen französischen wissenschaftlichen Einrichtungen, darunter das Centre National de la Recherche Scientifique, die Universität Montpellier und das Institut Curie, abgeschlossen. Gegründet 2013, hat Abivax S.A. seinen Sitz in Paris, Frankreich.
Unternehmen & Branche
| Name | Abivax S.A. |
|---|---|
| Ticker | ABVX |
| CIK | 0001956827 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 00370M103 |
|---|---|
| ISIN | US00370M1036 |
| Typ | ADR |
| Marktkapitalisierung | 6,34 Mrd. USD |
| Beta | 0,34 |
| Dividendenrendite | 0,00 % |
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-04 | 971 | 117,61 | 114.199 |
| 2026-05-01 | 2 | 117,38 | 235 |
| 2026-04-24 | 110 | 113,00 | 12.430 |
| 2026-04-23 | 35 | 115,99 | 4.060 |
| 2026-04-17 | 1.874 | 122,47 | 229.509 |
| 2026-04-15 | 3.835 | 125,80 | 482.443 |
| 2026-04-07 | 810 | 119,47 | 96.771 |
| 2026-03-31 | 86.183 | 101,50 | 8.747.575 |
| 2026-03-26 | 4.394 | 110,70 | 486.416 |
| 2026-03-20 | 4.929 | 123,03 | 606.415 |
| 2026-03-16 | 401 | 115,50 | 46.316 |
| 2026-02-24 | 20 | 132,91 | 2.658 |
| 2026-02-23 | 86.711 | 130,35 | 11.302.779 |
| 2026-02-10 | 14.266 | 119,78 | 1.708.781 |
| 2026-02-05 | 5.589 | 113,57 | 634.743 |
| 2026-02-04 | 15.019 | 113,32 | 1.701.953 |
| 2026-02-02 | 1.454 | 111,15 | 161.612 |
| 2026-01-30 | 2.987 | 113,54 | 339.144 |
| 2026-01-28 | 1.125 | 118,89 | 133.751 |
| 2026-01-26 | 27.177 | 122,12 | 3.318.855 |
| 2026-01-22 | 2.232 | 120,01 | 267.862 |
| 2026-01-21 | 9.905 | 118,84 | 1.177.110 |
| 2026-01-20 | 30 | 117,10 | 3.513 |
| 2026-01-15 | 4.000 | 125,01 | 500.040 |
| 2026-01-14 | 865.448 | 119,64 | 103.542.199 |
| 2026-01-13 | 929.688 | 118,00 | 109.703.184 |
| 2026-01-09 | 171 | 115,49 | 19.749 |
| 2026-01-08 | 500 | 126,48 | 63.240 |
| 2025-12-31 | 6.100 | 138,34 | 843.874 |
| 2025-12-30 | 43 | 140,40 | 6.037 |
| 2025-12-26 | 1.735 | 145,31 | 252.113 |